Release Date: 24/10/11 15:13 Summary: Suspension from Official Quotation Price Sensitive: Yes Download Document 24.97KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%